192 results
8-K
EX-99.1
WINT
Windtree Therapeutics, Inc.
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
) a decrease of $0.1 million in personnel costs due to headcount reductions; partially offset by (iv) the reversal of $0.5 million in incentive bonus
8-K
EX-99.1
6q6by1rues
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
xdbm61ze6xkn4b79duog
28 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
vysjm86
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm
8-K
EX-1.1
bkwnf9xak 10458xx
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
424B4
v2j8x
20 Apr 23
Prospectus supplement with pricing info
6:03pm